20928 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals alpha-Glycoproteins
OLIGONUCLEOTIDE ENCODING A TISSUE INHIBITOR OF METALLOPROTEASES PROTEIN FOR MEDICAL USE IN MAMMALS
#2CALSEQUESTRIN-BASED METAL ION REACTIVE PARTICLE AND USES THEREOF
#3MACROPHAGE POLARIZING ONCOLYTIC HERPES SIMPLEX VIRUS FOR CANCER THERAPY
#4METHODS OF PREPARATION OF SECRETOMES, AND USES THEREOF
#5Compositions for Treating Pathological Calcification Conditions, and Methods Using Same
#6TARGETED OESOPHAGEAL ADMINISTRATION OF ZN-ALPHA2-GLYCOPROTEINS (ZAG), METHODS AND FORMULATIONS THEREOF
#7PROTEIN FUNCTIONALIZED HYALURONIC ACID COATED CHITOSAN NANOPARTICLE AND METHOD OF PREPARATION
#8GLYCOPROTEINS HAVING LIPID MOBILIZING PROPERTIES AND THERAPEUTIC USES THEREOF
#9MATERIALS AND METHODS FOR EXTRACELLULAR VESICLE-ASSOCIATED DISEASES
#10GLYCOPROTEINS HAVING LIPID MOBILIZING PROPERTIES AND THERAPEUTIC USES THEREOF
#11COMPOSITIONS AND METHODS FOR BODY CONTOURING AND SURGICAL PROCEDURES
#12Application of skeletal muscle secreted factor THBS4 in preparation of drug for improving systemic glucose and lipid metabolism
#13IMMUNE SUPPRESSING NANOPARTICLES FOR ROBUST SENSITIZATION OF DRUG-RESISTANT CANCER
#14Fetuin A for Treatment of Renal Disorders
#15POLYPEPTIDES FOR INDUCING TOLERANCE TO FACTOR VIII
#16TARGETED OESOPHAGEAL ADMINISTRATION OF ZN-ALPHA2-GLYCOPROTEINS (ZAG), METHODS AND FORMULATIONS THEREOF
#17COMPOSITION FOR PREVENTION OR TREATMENT OF HAIR LOSS INCLUDING HAPLN1
#18Compositions for treating pathological calcification conditions, and methods using same
#19Glyco-engineered immunization antigens
#20Compositions and Structures for Regenerating Defective or Absent Myocardium
#21Methods for Regenerating Defective or Absent Myocardium
#22PROTEIN FUNCTIONALIZED HYALURONIC ACID COATED CHITOSAN NANOPARTICLE AND METHOD OF PREPARATION
#23GLYCOPROTEINS HAVING LIPID MOBILIZING PROPERTIES AND THERAPEUTIC USES THEREOF
#24Means and Methods for Generating Complex Glycans Derived From Fungal Engineered Hosts
#25Artificial exosome composition and related methods
#26Animal plasma or fractions thereof for use in treating cognitive impairment disorders in humans and companion animals
#27BIOMARKER PANEL FOR MONITORING KIDNEY HEALTH
#28SUMO AND USES THEREOF
#29Methods for preparing modified von Willebrand Factor
#30Methods and compositions for treating, inhibiting, and/or preventing heterotopic ossification
#31Compositions for Regenerating Defective or Absent Myocardium
#32Methods for preparing modified von Willebrand factor
#33GLYCOPROTEINS HAVING LIPID MOBILIZING PROPERTIES AND THERAPEUTIC USES THEREOF
#34GLYCOPROTEINS HAVING LIPID MOBILIZING PROPERTIES AND THERAPEUTIC USES THEREOF
#35Materials and methods for extracellular vessicle-associated diseases
#36STEM CELL COMPOSITIONS FOR COSMETIC AND DERMATOLOGIC USE
#37ZAG-derived peptide and use thereof
#38Methods for treating pseudoxanthoma elasticum (PXE)
#39Method for treating infectious diseases using a composition comprising plasma-derived immunoglobulin M (IgM)
#40Compositions for treating pathological calcification conditions, and methods using same
#41REDUCTION OF LIPASE ACTIVITY IN PRODUCT FORMULATIONS
#42Artificial exosome composition and related methods
#43CD47 blockade therapy by HDAC inhibitors
#44Compositions for treating pathological calcification conditions, and methods using same
#45Means and methods for generating complex glycans derived from fungal engineered hosts
#46PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING CANCER OR CANCER METASTASIS, CONTAINING FSTL1 PROTEIN AS ACTIVE INGREDIENT
#47TARGETED OESOPHAGEAL ADMINISTRATION OF ZN-ALPHA2-GLYCOPROTEINS (ZAG), METHODS AND FORMULATIONS THEREOF
#48USE OF FIBULIN-5 FOR THE TREATMENT OF KELOID SCARS
#49GLYCOPROTEINS HAVING LIPID MOBILIZING PROPERTIES AND THERAPEUTIC USES THEREOF
#50Composition for the Treatment of Joint Conditions
#51GLYCOPROTEINS HAVING LIPID MOBILIZING PROPERTIES AND THERAPEUTIC USES THEREOF
#52Reduction of lipase activity in product formulations
#53Compositions for Regenerating Defective or Absent Myocardium
#54Methods for preparing modified von Willebrand factor
#55Targeting GIV-GEF-GI signaling for treating diverse diseases
#56Compositions for treating pathological calcification conditions, and methods using same
#57Compositions for treating pathological calcification conditions, and methods using same
#58Compositions for treating pathological calcification conditions, methods, and host cells using the same
#59Aortopathy
#60Method of using insulin for controlling glycosylation of recombinant glycoprotein
#61Compositions for treating pathological calcification conditions, and methods using same
#62Compositions for treating pathological calcification conditions, and methods using same
#63Compositions for regenerating defective or absent myocardium
#64Prophylactic agent and therapeutic agent for fibrodysplasia ossificans progressiva
#65Glycoproteins having lipid mobilizing properties and therapeutic uses thereof
#66Method for treating infectious diseases using a composition comprising plasma-derived immunoglobulin M (IgM)
#67Targeted oesophageal administration of ZN-α-glycoproteins (ZAG), methods and formulations thereof
#68Reduction of lipase activity in product formulations
#69Methods for treatment of amyotrophic lateral sclerosis with follistatin fusion proteins
#70GLYCOPROTEINS HAVING LIPID MOBILIZING PROPERTIES AND THERAPEUTIC USES THEREOF
#71Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism
#72Compositions for regenerating defective or absent myocardium
#73Compositions for regenerating defective or absent myocardium
#74Compositions for regenerating defective or absent myocardium
#75Methods of treating and preventing infections and associated conditions
#76TREATMENT OF CANCER
#77Bioactive compositions and methods for their preparation and use
#78Compositions And Methods For Enhancing Sialic Acid Levels In Tissue
#79Compositions and methods for diagnosing and treating Sjogren's Syndrome
#80GLYCOPROTEINS HAVING LIPID MOBILIZING PROPERTIES AND THERAPEUTIC USES THEREOF
#81Compositions for regenerating defective or absent myocardium
#82GLYCOPROTEINS HAVING LIPID MOBILIZING PROPERTIES AND THERAPEUTIC USES THEREOF
#83TREATMENT OF CANCER WITH ALK1 ANTAGONISTS
#84Multi-Needle Injection Apparatus and System for Delivering Pharmacological Agents to Biological Tissue
#85Compositions and Methods For Enhancing Sialic Acid Levels In Tissue
#86Compositions for regenerating defective or absent myocardium
#87Glycoproteins Having Lipid Mobilizing Properties an Therapeutic Uses Thereof
#88Compositions for regenerating defective or absent myocardium
#89Compositions for regenerating defective or absent myocardium
#90Compositions for regenerating defective or absent myocardium
#91Alpha 1-acid glycoprotein, alpha 2-HS glycoprotein, alpha 1-antitrypsin, and fragments thereof induce apoptosis in cancer cell lines
#92Glycoproteins Having Lipid Mobilizing Properties and Therapeutic Uses Thereof
#93Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism
#94STEM CELL TARGETING METHODS
#95SMALL MOLECULES FOR THE REDUCTION OF HIGH BLOOD GLUCOSE LEVEL
#96Pharmaceutical Composition Having Inhibitory Effect on Overproduction and Accumulation of Extracellular Matrix
#97Methods and compositions for administering stem cells
#98Methods and compositions for regenerating tissue
#99Methods and compositions for directing stem cells to the liver
#100Methods and compositions for directing stem cells to the heart
#101Methods and compositions for mobilizing stem cells
#102Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs
#103Compositions for regenerating defective or absent myocardium
#104Compositions for regenerating defective or absent myocardium
#105Compositions for regenerating defective or absent myocardium
#106Compositions for regenerating defective or absent myocardium
#107Compositions for regenerating defective or absent myocardium
#108Protein compositions for promoting wound healing and skin regeneration
#109Compositions for regenerating defective or absent myocardium
#110Polypeptide for the treatment of cancer and a method for preparation thereof
#111Polypeptide for the treatment of cancer and a method for preparation thereof
#112Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs
#113Alpha 1-acid glycoprotein, alpha 2-HS glycoprotein, alpha 1-antitrypsin, and fragments thereof induce apoptosis in cancer cell lines
#114Polypeptide for the treatment of cancer and a method for preparation thereof
#115Compounds and methods for downregulating the effects of TGF-beta
#116Pharmaceutical composition having inhibitory effect on overproduction and accumulation of extracellular matrix